Jefferies Sees Huge Upside in Shares of Rigel Pharma (RIGL)

November 7, 2012 12:45 PM

Jefferies maintained a Buy rating on Rigel Pharmaceuticals (NASDAQ: RIGL) and raised its price target to $21.00 (from $14.00).

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found